Amgen Boosts Outlook Despite Pricing Pressure for Some Drugs

Amgen Inc. boosted its financial outlook for the year, after the drugmaker posted better-than-expected results in the third quarter despite an erosion in some treatment prices.

  • The company said it expects adjusted earnings per share for the full year of…

Click here to view the original article.